FAQ:

What is Semaglutide and Tirzepatide?

Both Semaglutide (Ozempic) and Tirzepatide (Mounjaro) are FDA approved injectables that are glucagon-like peptide -1 (GLP-1) agonist that's administered once weekly for obesity.

How does it work for weight loss?

These peptides work in a variety of ways. GLP-1 is an incretin hormone that plays a role in your appetite, digestion, and blood sugar. Incretins are hormone released by your small intestines, which are sent out by your body after you have eaten a meal to help lower your blood sugar by triggering insulin and blocking sources of sugar. In return it helps slow down how quickly your food leaves your stomach (called gastric emptying). The result of these actions causes you to feel full longer, lowering your appetite and causing you to lose weight. It can cause an average of 15-20% in weight loss reduction.

How is it administered?

These are once weekly self injections given on the same day every week. It can be given at any time of the day, and you can take it with or without food. It is injected just under your skin (subcutaneously) in your abdomen.

What are the side effects?

Since these medications slow down how quickly food leaves your stomach, you may experience symptoms such as nausea and vomiting. But these can be managed with a varitety of treatment options.